NCI Meeting Scheduled for Fri. Feb 21

There will be a meeting next week at the National Cancer Institute (NCI) dedicated to pediatric cancer drug development. The National Cancer Institute (NCI) will hold its 64th Meeting of the Director’s Consumer Liaison Group (DCLG) on Friday, February 21, 2014 from 9:30 a.m. to 4:00 p.m. on the National Institutes of Health (NIH) Campus in Bethesda, MD. The meeting will focus on barriers to drug development in pediatric cancer research and will include participants from the pediatric cancer advocacy community, as well as private and public sector presenters. The panels will discuss the State of Pediatric Cancer Research, Potential […]

Read more

Successful Collaboration: Leveraging an Established Grant Review Process

This collaborative research effort was due to childhood cancer groups coming together as part of CAC2. When the founders of Florida-based I Care I Cure Childhood Cancer Foundation approached Jay and Liz Scott of Alex’s Lemonade Stand Foundation at one of the early C3U (now CAC2) meetings, it was the beginning of a productive and fruitful collaboration that has increased the reach of both organizations’ grantmaking. Alex’s Lemonade Stand Foundation (ALSF) has a successful track record of funding cutting-edge medical research – more than 350 projects since 2006. To identify and select the best projects, ALSF has assembled a Scientific [...] Read more

CAC2 Member Blog–Curing Childhood Cancer: “My What If?”

By CAC2 Member Amber Larkin, Noah's Light Foundation Last fall, Amber Larkin stepped onto the stage for 18 minutes at the TEDx Orlando event in the Winter Garden Theater. Most of those in attendance had no idea that the contents of those 18 minutes would reshape the way they think about cancer forever. Amber’s compelling story of her son, Noah, his battle with brain cancer and the hope that has resulted from her tireless work to find a cure brought the audience to laughter, to tears and eventually to their feet. We are pleased to share Amber’s inspiring speech with [...] Read more

CAC2 Member Blog–Be A Voice for the Children

By CAC2 Members Dena Sherwood, Arms Wide Open Childhood Cancer Foundation and Mike Gilette, The Truth 365 Tonight, 1/21, at 8 pm ET:  Join forces with over 700 organizations and groups by helping launch the powerful short film, “Be a Voice for the Children.” Produced by the Emmy® Award-Winning team at The Truth 365, this 8-minute video features interviews with 15 young cancer fighters who share their fears, frustrations, dreams and goals. They also tell viewers exactly what they can do to help make childhood cancer research a national priority. This grassroots effort is for the entire childhood cancer community and designed […]

Read more

From the Congressional Childhood Cancer Caucus–Concerns about Daunorubicin Shortage

Link to Original on the Congressional Childhood Cancer Caucus website Nov 12, 2013 Caucus Asks Questions about the Ongoing Shortage of Daunorubicin WASHINGTON, D.C. – Out of concern over the ongoing shortage of daunorubicin, an essential therapy in the treatment of leukemia in children, Representatives McCaul and Van Hollen, the co-chairs of the Congressional Childhood Cancer Caucus, sent letters to the Food and Drug Administration  (FDA) and Teva Pharmaceuticals, the sole remaining supplier of the drug. As of this summer, Teva Pharmaceuticals was the sole remaining supplier of the drug. Teva recently informed the FDA that the drug was in limited supply and that […]

Read more

CAC2 Member Blog–The Power of Color

By CAC2 Member Tony Stoddard, Sophia’s Fund There are four boxes in this picture; each box contains colors, a pink box, a green box, a rainbow colored box, and a gold box. When I asked people what the pink box meant to them most answered, “breast cancer” When I asked about the green box a great deal of people said, “The environment or recycling” When I asked about the rainbow colored box a lot of people replied, “gay rights” When I asked what the gold box meant to them I received answers such as, “I don’t know, or it means […]

Read more

Complete Remission Induced By Dendritic Cell Vaccine For Relapsed Neuroblastoma Patient

This collaborative research effort was due to childhood cancer groups coming together as part of CAC2. One year after his last treatment, a six-year-old boy with recurrent neuroblastoma is in complete remission for his high-risk metastatic cancer. Doctors reported this case study in the January 2013 issue of Pediatrics, the journal of the American Academy of Pediatrics, which was funded in part by a joint grant from the Andrew McDonough B+ Foundation, Pierce Phillips Charity and Solving Kids' Cancer. Current treatments for high-risk neuroblastoma patients include chemotherapy, radiation therapy, surgery, stem cell transplant, and immunotherapy. Less than half of the [...] Read more

Enquire now

Give us a call or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours on business days.